11/21
08:14 am
wve
Rating for WVE
Low
Report
Rating for WVE
11/21
08:14 am
wve
Rating for WVE
Low
Report
Rating for WVE
11/13
10:08 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
10/31
10:42 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
10/21
09:49 am
wve
Rating for WVE
Low
Report
Rating for WVE
10/21
09:49 am
wve
Rating for WVE
Low
Report
Rating for WVE
10/17
10:28 am
wve
Rating for WVE
Low
Report
Rating for WVE
10/17
08:55 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
10/16
01:34 pm
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock, up previously from $13.00.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock, up previously from $13.00.
10/16
01:34 pm
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock, up previously from $13.00.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock, up previously from $13.00.
10/16
01:26 pm
wve
Rating for WVE
Low
Report
Rating for WVE
10/16
01:26 pm
wve
Rating for WVE
Low
Report
Rating for WVE
10/16
01:21 pm
wve
Rating for WVE
Low
Report
Rating for WVE
10/16
01:21 pm
wve
Rating for WVE
Low
Report
Rating for WVE
10/16
01:12 pm
wve
Rating for WVE
Low
Report
Rating for WVE
10/4
11:37 am
wve
Rating for WVE
Low
Report
Rating for WVE
10/4
11:37 am
wve
Rating for WVE
Low
Report
Rating for WVE
9/27
09:42 am
wve
Rating for WVE
Low
Report
Rating for WVE
9/27
09:04 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $13.00 price target on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $13.00 price target on the stock.
9/19
07:58 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at B. Riley. They set a "buy" rating and a $11.00 price target on the stock.
Medium
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at B. Riley. They set a "buy" rating and a $11.00 price target on the stock.
9/19
07:58 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at B. Riley. They set a "buy" rating and a $11.00 price target on the stock.
Medium
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at B. Riley. They set a "buy" rating and a $11.00 price target on the stock.
9/18
04:39 pm
wve
Wave Life Sciences initiated with bullish view at B. Riley
Medium
Report
Wave Life Sciences initiated with bullish view at B. Riley
9/18
04:39 pm
wve
Wave Life Sciences initiated with bullish view at B. Riley
Medium
Report
Wave Life Sciences initiated with bullish view at B. Riley
9/9
08:26 am
wve
Rating for WVE
High
Report
Rating for WVE
9/9
08:01 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $10.00 price target on the stock.
High
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $10.00 price target on the stock.